Urinary Incontinence News and Research

Latest Urinary Incontinence News and Research

Researchers identify five SNPs linked with aggressive, lethal prostate cancer

An international team of researchers led by Fred Hutchinson Cancer Research Center has identified five inherited genetic variants that are strongly associated with aggressive, lethal prostate cancer.

17 Aug 2011

First bioengineered anal sphincter for treatment of fecal and urinary incontinence

Researchers have built the first functional anal sphincters in the laboratory, suggesting a potential future treatment for both fecal and urinary incontinence. Made from muscle and nerve cells, the sphincters developed a blood supply and maintained function when implanted in mice.

10 Aug 2011

Nearly half of men expect better recovery from side-effects of prostate cancer surgery

Nearly half of men undergoing surgery for prostate cancer expect better recovery from the side effects of the surgery than they actually attain one year after the operation, a University of Michigan Comprehensive Cancer Center study finds.

10 Aug 2011

Allergan receives positive opinion from Irish Medicines Board for BOTOX

Allergan is pleased to announce that BOTOX has received a positive opinion from the Irish Medicines Board for the management of urinary incontinence in adults with neurogenic detrusor overactivity (NDO) resulting from neurogenic bladder due to stable sub-cervical spinal cord injury, or multiple sclerosis.

8 Aug 2011

A guide to safe and informed recovery after prostate cancer

Prostate cancer is the number two killer of American men, second only to lung cancer. It is a disease that affects more than 2 million American men, and in 2010 there were over 218,000 new diagnoses.

2 Aug 2011

Three flutemetamol clinical abstracts to be presented at 2011 Alzheimer's Association ICAD

Recent clinical research data reported that the investigational amyloid imaging agent [18F]Flutemetamol showed highly consistent image interpretation1 and showed comparable in vitro binding to the Pittsburgh Compound-B investigational imaging agent3.

21 Jul 2011

Transvaginal placement of surgical mesh for pelvic organ prolapse may pose greater risk, warns FDA

The U.S. Food and Drug Administration today issued an updated safety communication warning health care providers and patients that surgical placement of mesh through the vagina to repair pelvic organ prolapse may expose patients to greater risk than other surgical options.

14 Jul 2011

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced an exclusive licensing agreement for Watson to commercialize Antares' topical oxybutynin gel product in the U.S. and Canada.

11 Jul 2011

Urinary incontinence after child birth increases risk of postpartum depression

Women with urinary incontinence after giving birth are almost twice as likely to develop postpartum depression as those without incontinence, according to a new study led by Wendy Sword, a professor in McMaster University's School of Nursing.

20 Jun 2011

Prior GID diagnosis impacts health outcomes of patients with Parkinson's

A new study investigating the incidence and impact of gastrointestinal disorders (GID) among patients with Parkinson's disease (PD) found that patients who received both a PD diagnosis and a prior GID diagnosis appeared to have worse health outcomes compared to patients who received a diagnosis for PD with no prior GID diagnosis.

16 Jun 2011

Patent infringement suit filed against Impax Laboratories in connection with Detrol

Impax Laboratories, Inc. today confirms that Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB have filed suit for patent infringement against Impax in the United States District Court for the District of New Jersey in connection with Detrol (tolterodine tartrate) immediate-release, 1 mg and 2 mg tablets.

4 Jun 2011

Wireless near-infrared spectroscopy can effectively detect bladder disease in children

A cell phone-sized, wireless near-infrared device is as reliable as the current "gold standard" invasive tests in determining bladder disease, according to a study by researchers at the University of British Columbia, Vancouver Coastal Health and the Child & Family Research Institute (CFRI).

1 Jun 2011

UK's NICE issues guidance on PTNS treatment for faecal incontinence

Uroplasty, Inc., announced today that the United Kingdom's National Institute for Health and Clinical Excellence issued guidance on percutaneous tibial nerve stimulation for the treatment of faecal incontinence.

31 May 2011

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

Astellas Pharma US, Inc., U.S. subsidiary of Astellas Pharma Inc., today announced the results of a pivotal phase III clinical trial for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), which show mirabegron significantly improves key OAB symptoms – urinary incontinence and frequency of micturition compared with placebo.

18 May 2011

Caldera's Desara Mini implant for Stress Urinary Incontinence receives CE Mark certification

Caldera Medical today announced that it has achieved CE Mark certification for its Desara Mini implant, an extension of its popular Desara brand for the treatment of Stress Urinary Incontinence.

6 May 2011

SRS Medical announces pelvic health program for women

SRS Medical today announced the formation of Restore Continence™, a women's pelvic health program based on the use of a comprehensive suite of medical devices for diagnosing and treating urinary incontinence.

3 May 2011

Simbionix to exhibit new training simulator for pelvic floor repair at ACOG

Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is pleased to announce its new training simulator for pelvic floor repair, to be exhibited for the first time at the ACOG 59th Annual Clinical Meeting in Washington, DC, April 30- May 4, 2011.

3 May 2011

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.

25 Apr 2011

Physiotherapy Associates inaugurates new clinic in Grand Haven, MI

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, recently opened a new physical therapy clinic in Grand Haven, MI.

22 Apr 2011

NHIC to cover PTNS using Uroplasty's Urgent PC Neuromodulation System for overactive bladder

Uroplasty, Inc. announced that NHIC Corp., the Medicare carrier for Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont, will cover posterior tibial nerve stimulation (PTNS) using Uroplasty's Urgent® PC Neuromodulation System for the treatment of overactive bladder and associated symptoms, effective May 22, 2011.

8 Apr 2011

Urinary Incontinence News and Research

Latest Urinary Incontinence News and Research

Researchers identify five SNPs linked with aggressive, lethal prostate cancer

First bioengineered anal sphincter for treatment of fecal and urinary incontinence

Nearly half of men expect better recovery from side-effects of prostate cancer surgery

Allergan receives positive opinion from Irish Medicines Board for BOTOX

A guide to safe and informed recovery after prostate cancer

Three flutemetamol clinical abstracts to be presented at 2011 Alzheimer's Association ICAD

Transvaginal placement of surgical mesh for pelvic organ prolapse may pose greater risk, warns FDA

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Urinary incontinence after child birth increases risk of postpartum depression

Prior GID diagnosis impacts health outcomes of patients with Parkinson's

Patent infringement suit filed against Impax Laboratories in connection with Detrol

Wireless near-infrared spectroscopy can effectively detect bladder disease in children

UK's NICE issues guidance on PTNS treatment for faecal incontinence

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

Caldera's Desara Mini implant for Stress Urinary Incontinence receives CE Mark certification

SRS Medical announces pelvic health program for women

Simbionix to exhibit new training simulator for pelvic floor repair at ACOG

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Physiotherapy Associates inaugurates new clinic in Grand Haven, MI

NHIC to cover PTNS using Uroplasty's Urgent PC Neuromodulation System for overactive bladder

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Urinary Incontinence News and Research

Latest Urinary Incontinence News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in